do glp 1 agonists have cardiovascular benefit GLP-1 in Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies GLP-1 Receptor Agonists and SGLT2
Description
Notably, SGLT2i have also been shown to be effective for the treatment of patients with HFmrEF and HFpEF, with their efficacy independent of ejection fraction
Back Karamanou, M, Protogerous, A, Tsoucalas, G, et al (10 Jan 2016) 'Milestones in the history of diabetes mellitus: The main contributors', World Journal Diabetes , 7/1, 1-7
This allows for less frequent dosing, which may result in higher efficacy [38]
82100869 to P.Y., nos
Nonmedical triggers for switching included patient preference, cost, formulary changes and insurance mandates
Shen, W
